Original articleNitrite confers protection against myocardial infarction: Role of xanthine oxidoreductase, NADPH oxidase and KATP channels
Introduction
Until recently the nitrite anion (NO2−) has been considered to be an oxidation product of nitric oxide, useful as an index of the catalytic activity of nitric oxide synthase [1]. Approximately 80–90% of plasma nitrite is derived from endothelial nitric oxidase synthase derived nitric oxide [2]. Recently it has been shown that plasma cerulloplasmin has a nitric oxide oxidase activity and may play a role in the conversion of nitric oxide to nitrite in vivo [3]. The nitrite anion, which is present between 0.2 and 10 μM in the blood and tissues [4], [5], may represent a storage form of nitric oxide that is made available under conditions of oxygen deprivation to maintain cell survival. Cardioprotective effects of nitrite have recently been demonstrated. Reduction of nitrite to nitric oxide during ischemia protects the heart against injury from ischemia–reperfusion [6], [7]. The underlying mechanisms by which nitrite is reduced to nitric oxide have not yet been fully defined. Of the candidates for nitrite reduction in vivo, deoxyhemoglobin, deoxymyoglobin and xanthine oxidoreductase have been shown to have an oxygen-sensitive nitrite reductase activity [8], [9], [10]. Data suggest that deoxyhemoglobin plays a role in nitrite-dependent control of vascular tone during hypoxia [11], while xanthine oxidoreductase has been implicated in the cardioprotective effects of nitrite under conditions of oxygen deprivation [7]. In mammals, xanthine oxidoreductase exists in two interconvertible forms, xanthine dehydrogenase (EC 1.1.1.204), which predominates in vivo, and xanthine oxidase (EC 1.1.3.22). The extent to which nitrite alters the activity of xanthine dehydrogenase and xanthine oxidase during myocardial ischemia is not known.
In this study we have selected in vitro and in vivo models of regional myocardial ischemia and reperfusion to determine the ability of nitrite to confer acute cardioprotection in both the presence and absence of hemoglobin. The objectives of our study were to determine (1) the ability of nitrite and nitrate to confer protection against injury from regional ischemia–reperfusion in vivo and in vitro and (2) to assess the contribution of xanthine oxidoreductase, nitric oxide synthase, NADPH oxidase and the sarcolemmal and mitochondrial ATP-sensitive potassium (KATP) channels to nitrite-induced cardioprotection.
Section snippets
Materials and methods
Male Sprague Dawley rats at 8 weeks of age used in this study received humane care in compliance with the Guide for the Care and Use of Laboratory Animals formulated by the National Research Council, 1996.
Nitrite, nitrate and cardioprotection in vivo
We determined the dose–response relationship for nitrite to confer protection against injury from myocardial infarction using an in vivo model of regional myocardial ischemia and reperfusion. Rats were treated with an I.V. bolus of sodium nitrite (0.04, 0.4, 1.0, 4.0, 7.0 or 10.0 mg/kg) 15 min prior to 30 min occlusion of the left anterior descending coronary artery and 2 h of reperfusion. The effects of increasing nitrite dosage on hemodynamic parameters in the in vivo rat model of ischemia
Discussion
The present data indicate that nitrite protects the heart against injury from infarction and decreased post-ischemic ventricular function in both in vivo and in vitro models of ischemia/reperfusion. This effect of nitrite is dose- and concentration-dependent with optimal protection occurring at 4 mg/kg I.V. in vivo and 10 μM in vitro. Nitrite conferred cardioprotection over the range of 10–100 μM in vitro. One hundred micromolar nitrite also vasodilates aortic ring preparations [21], with
Acknowledgments
This work was supported in part by grants HL54075 (JEB), GM55792 (NH) and HL08361 (GJG) from the National Institutes of Health.
References (42)
- et al.
Increased resistance to myocardial ischemia in the brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90
J. Mol. Cell. Cardiol.
(2005) - et al.
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals
Free Radical Biol. Med.
(2003) - et al.
The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions
Free Radical Biol. Med.
(2006) - et al.
The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry
J. Biol. Chem.
(2005) - et al.
Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation
J. Biol. Chem.
(2004) - et al.
K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2
J. Mol. Cell. Cardiol.
(2003) - et al.
A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues
Free Radic Biol. Med.
(1989) - et al.
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase
J. Biol. Chem.
(2000) - et al.
Activation of guanylate cyclase from rat liver and other tissues by sodium azide
J. Biol. Chem.
(1975) Structure and function of xanthine oxidoreductase: where are we now?
Free Radic Biol. Med.
(2002)
The proportion of xanthine oxidase activity of total xanthine oxidoreductase activity in situ remains constant in rat liver under various (patho)physiological conditions
Hepatology
Xanthine oxidase catalyzes anaerobic transformation of organic nitrates to nitric oxide and nitrosothiols: characterization of this mechanism and the link between organic nitrate and guanylyl cyclase activation
J. Biol. Chem.
NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction
J. Mol. Cell. Cardiol.
Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites
J. Biol. Chem.
A new route to peroxynitrite: a role for xanthine oxidoreductase
FEBS Lett.
Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators
Biochem. Biophys. Res. Commun.
Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation
J. Biol. Chem.
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity
Biochem. Biophys. Res. Commun.
K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms
J. Mol. Cell. Cardiol.
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis
Nat. Chem. Biol.
Chemical nature of nitric oxide storage forms in rat vascular tissue
Proc. Natl. Acad. Sci. U. S. A.
Cited by (123)
Advances in nitric oxide regulators for the treatment of ischemic stroke
2023, European Journal of Medicinal ChemistrySkeletal muscle as a reservoir for nitrate and nitrite: The role of xanthine oxidase reductase (XOR)
2022, Nitric Oxide - Biology and ChemistryInfluence of plasma halide, pseudohalide and nitrite ions on myeloperoxidase-mediated protein and extracellular matrix damage
2022, Free Radical Biology and MedicineHeme oxygenase-1, carbon monoxide, and malaria – The interplay of chemistry and biology
2022, Coordination Chemistry ReviewsHuman and rodent red blood cells do not demonstrate xanthine oxidase activity or XO-catalyzed nitrite reduction to NO
2021, Free Radical Biology and MedicineCitation Excerpt :Importantly, these hypoxic/ischemic conditions limit NO generation from endothelial nitric oxide synthase and have incentivized the supposition that XO- and XDH-mediated NO generation provides compensation [14]. Numerous in vivo reports validate the in vitro findings and demonstrate a clear XOR-dependence on beneficial outcomes associated with nitrite treatment in various inflammatory processes including those associated with the vasculature where vascular-associated XOR has been contributory [11,12,25–29]. However, the details regarding micro-environmental conditions requisite for XOR-mediated NO generation are not completely understood and may involve cooperation with alternative agents such as sulfide to afford maximal benefit [30].
Nitrite and myocardial ischaemia reperfusion injury. Where are we now?
2021, Pharmacology and Therapeutics